Atorvastatin sodium
- Level
- Commodity
- Parent
- 51321700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51321712This classification denotes a hmg-coa reductase inhibitor with the molecular formula C33H34FN2O5.NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DN43058TIV. European Medicines Agency schedules atorvastatin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35008. Most nations, for tariff and trade purposes, schedule atorvastatin sodium under HS 29339990 and SITC 51577. As of Q4 2014, ATORVASTATIN SODIUM remains US FDA's Preferred Term for this commodity. Atorvastatin sodium bears US NLM identifiers UMLS ID C2698196 and NCI Concept Code C78676. SMILES: CC(C)C1C(C(C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2CCC(CC2)F)C3CCCCC3)C(=O)NC4CCCCC4.[NA+].
Same parent
Under 51321700 · 14Activities that produce or sell this
KBLI · 8Inherited from family 51320000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.